Related references
Note: Only part of the references are listed.Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide
Toshiaki Yujiri et al.
ANNALS OF HEMATOLOGY (2014)
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
Chiun Hsu et al.
HEPATOLOGY (2014)
AASLD Clinical Practice Guidelines: A Critical Review of Scientific Evidence and Evolving Recommendations
Christopher Koh et al.
HEPATOLOGY (2013)
Immunosuppression and HBV Reactivation
Daniel Shouval et al.
SEMINARS IN LIVER DISEASE (2013)
A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin’s lymphoma patient
Chunchen Wu et al.
VIROLOGICA SINICA (2013)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
Yu Xuan Koo et al.
ANNALS OF HEMATOLOGY (2011)
Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
Shigeru Kusumoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
Maria Luisa Manzano-Alonso et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
Andrew S. Artz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection
Ya-Yu Wang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Diabetes mellitus and hepatocellular carcinoma: Comparison of Chinese patients with and without HBV-related cirrhosis
Chun Gao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Tara N. Palmore et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients
Mehmet Demir et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for future strategies
Yen-Hsuan Ni et al.
GASTROENTEROLOGY (2007)
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
BRITISH JOURNAL OF CANCER (2004)
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination
CY Lu et al.
HEPATOLOGY (2004)
Immunogenicity of 10 and 20 μg hepatitis B vaccine in a two-dose schedule
N ul-Haq et al.
VACCINE (2003)
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
AL Cheng et al.
HEPATOLOGY (2003)
High-dose cytosine arabinoside-induced cutaneous reactions
P Cetkovská et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2002)
Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis
H Kojima et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination
YH Ni et al.
ANNALS OF INTERNAL MEDICINE (2001)
Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia
K Ishiga et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)